Funding for this research was provided by:
Fogarty International Center (R25TW007090)
Received: 25 April 2019
Accepted: 3 February 2020
First Online: 15 April 2020
Ethics approval and consent to participate
: The study protocol was reviewed and approved by the ethical review boards in Morocco (Comité d’Ethique Pour La Recherche Biomédicale, Casablanca), Egypt (National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt), and the USA (University of Maryland School of Medicine).Each participant received the IRB-approved written consent forms (IRBs from Egypt and Morocco). Participants’ questions about the study were answered after which each participant gave verbal consent, as their written signatures would have represented the only way to identify them. Prior to the start of the focus group discussion, participants confirmed their consent to participate, which was audio recorded without identifying information. This procedure was approved by both ethics review boards.
: Not applicable.
: The authors declare that they have no competing interests.